alexa

GET THE APP

Full Clinical and Endoscopic Remission Following Fecal Microbiota Transplant with Moderate-Severe Treatment-Resistant Ulcerative Colitis | OMICS International | Abstract
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Full Clinical and Endoscopic Remission Following Fecal Microbiota Transplant with Moderate-Severe Treatment-Resistant Ulcerative Colitis

Mihaela Laszlo1* and Pascu O1,2

1Regional Hepatology and Gastroenterology Institute, Cluj-Napoca, Romania

2University of Medicine and Pharmacy “Iuliu Hatieganu”, Cluj-Napoca, Romania

*Corresponding Author:
Mihaela Laszlo
Regional Hepatology and Gastroenterology Institute
Cluj-Napoca, 8 Babes Street, 400012 Cluj-Napoca, Romania
Tel: +40-264-597-256
Fax: +40-264-597-257
E-mail: [email protected]

Received date: March 11, 2014; Accepted date: April 25, 2014; Published date: April 30, 2014

Citation: Laszlo M and Pascu O (2014) Full Clinical and Endoscopic Remission Following Fecal Microbiota Transplant with Moderate-Severe Treatment-Resistant Ulcerative Colitis. J Gastroint Dig Syst 2:183. doi:10.4172/2161-069X.1000183

Copyright: © 2014 Laszlo M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Fecal microbiota transplantation (FMT) from healthy donors, is an effective alternative for treatment of Clostridium difficile–associated disease, it is being considered for several disorders such as inflammatory bowel disease, irritable bowel syndrome, and metabolic syndrome.

A 61 year old male with extensive ulcerative colitis since 2010 under biologic therapy from 2012 and with several acute relapses under treatment. The patient has been treated with FMT, clinical and biological remission was achieved.

This case highlights the value of characterizing temporally resolved microbiota dynamics for a better understanding of FMT efficacy and provides potentially useful diagnostic indicators for monitoring FMT success in the treatment of ulcerative colitis.

FMT seems to be a promising alternative treatment of frequent relapses for selected cases of ulcerative colitis

Keywords

Top